| Saham Diterbitkan | 10,376,109 shares |
| Saham Orang Dalam | 1,167,438 shares |
| Pemilikan Orang Dalam | 11.25 % |
| Jumlah Orang Dalam | 32 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mendapati syarikat dibeli oleh orang dalam korporat.
Ia adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat dengan tahap pengumpulan orang dalam yang paling tinggi. Model pemarkahan menggunakan gabungan bilangan bersih orang dalam yang membeli 90 hari sebelumnya, jumlah saham yang dibeli sebagai peratusan saham beredar, dan jumlah saham yang dimiliki oleh orang dalam. Nombor ini berjulat dari 0 hingga 100, dengan nombor yang lebih tinggi menunjukkan tahap pengumpulan yang lebih tinggi kepada rakannya, dan 50 adalah purata.
Kekerapan Kemas Kini: Harian
Skor Sentimen Pegawai
Skor Sentimen Pegawai mendapati syarikat dibeli oleh Pegawai Korporat.
Mengikut definisi Pegawai Korporat ialah Orang Dalam Korporat, tetapi tidak seperti beberapa Orang Dalam yang lain (10% Pemegang Saham dan Ahli Lembaga), Pegawai bekerja untuk syarikat tersebut setiap hari, dan mereka menggunakan wang mereka sendiri semasa berdagang . (10% Pemegang Saham dan Ahli Lembaga Pengarah selalunya pengurus dana yang menguruskan wang orang lain.) Oleh itu, dagangan orang dalam yang dibuat oleh Pegawai adalah lebih penting dan harus dilayan dengan sewajarnya.
Seperti Skor Sentimen Orang Dalam, Skor Sentimen Pegawai adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat yang mempunyai tahap pengumpulan pegawai tertinggi.
Kekerapan Kemas Kini: Harian
Metrik Orang Dalam Utama
Kad ini menunjukkan bagaimana kedudukan syarikat mengikut pelbagai metrik orang dalam. Kedudukan persentil menunjukkan cara syarikat ini dibandingkan dengan syarikat lain di pasaran AS. Kedudukan yang lebih tinggi menunjukkan keadaan yang lebih baik.
Sebagai contoh, adalah diterima umum bahawa pembelian orang dalam ialah penunjuk positif, jadi syarikat yang mempunyai lebih banyak pembelian orang dalam akan mendapat kedudukan lebih tinggi daripada syarikat yang kurang pembelian orang dalam (atau malah jualan orang dalam).
Peratusan Saham Beredar yang Dibeli oleh Orang Dalam (Kedudukan)
0.000 %( )
4952 out of 11224Peratusan Saham Beredar yang Dibeli oleh Orang Dalam ialah jumlah bilangan saham yang dibeli oleh orang dalam tolak jumlah bilangan saham yang dijual oleh orang dalam dalam tempoh 90 hari terakhir, dibahagikan dengan jumlah saham beredar dan didarab dengan 100.
Carta Dagangan Dalaman
Brainstorm Cell Therapeutics Inc. dagangan dalaman ditunjukkan dalam carta berikut. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Secara umumnya adalah menyalahi undang-undang bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat material dan bukan awam. Ini tidak bermakna haram untuk mereka membuat sebarang perdagangan dalam syarikat mereka sendiri. Walau bagaimanapun, mereka mesti melaporkan semua dagangan kepada SEC melalui Borang 4.
Senarai Orang Dalam dan Metrik Keberuntungan
Jadual ini menunjukkan senarai orang dalam yang diketahui dan dijana secara automatik daripada pemfailan yang didedahkan kepada SEC. Sebagai tambahan kepada nama, gelaran terkini dan pengarah, pegawai, atau 10% jawatan pemilik, kami menyediakan pegangan yang didedahkan terkini. Selain itu, apabila boleh, kami menyediakan sejarah prestasi perdagangan untuk orang dalam. Sejarah prestasi perdagangan ialah purata wajaran prestasi transaksi pembelian pasaran terbuka sebenar yang dibuat oleh orang dalam. Untuk mendapatkan maklumat lanjut tentang cara ini dikira, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang dalam | Purata Keuntungan (%) | Saham Dimiliki |
Berpecah Dilaraskan |
|---|---|---|---|
| ACC International Holdings Ltd. - | 67,053 | 4,470 | |
| ACCBT Corp. | 3,181,925 | ||
| Irit Arbel Director - [D] | 41,054 | 41,054 | |
| Sankesh Abbhi Director - [D] | 11,323 | 755 | |
| June Sherie Almenoff Director - [D] | 6,000 | 400 | |
| Arturo Araya Chief Commercial Officer - [O] | 8,608 | 574 | |
| Menghisteab Bairu Director - [D] | 24,000 | 24,000 | |
| Yoram Bibring Chief Financial Officer - [O] | 50,000 | 3,333 | |
| Dagher Ibrahim B. Chief Medical Officer - [O] | 535,742 | 535,742 | |
| Jacob A Frenkel Director - [D] | 43,777 | 43,777 |
| Orang dalam | Purata Keuntungan (%) | Saham Dimiliki |
Berpecah Dilaraskan |
|---|---|---|---|
| Fiorino Anthony S. Chief Executive Officer - [O] | 2,500 | 167 | |
| Mordechai Friedman Director - [D] | 0 | 0 | |
| Hartoun Hartounian EVP, Chief Operating Officer - [O] | 52,000 | 52,000 | |
| Adrian Harel | 70,000 | ||
| Avi Israeli | 133,334 | ||
| Kern Ralph Dr. COO and Chief Medical Officer - [O] | 223,310 | 14,887 | |
| Chaim Lebovits President & CEO - [O] | 200,960 | 200,960 | |
| Stacy Lindborg Director - [D] | 48,229 | 48,229 | |
| Nir Naor Director - [D] | 31,465 | 31,465 | |
| Alla Patlis See Remarks - [O] | 44,349 | 44,349 | |
| Alon Pinkas | 15,333 |
| Orang dalam | Purata Keuntungan (%) | Saham Dimiliki |
Berpecah Dilaraskan |
|---|---|---|---|
| Polverino Anthony J. Director - [D] | 25,730 | 25,730 | |
| Eyal Rubin CFO and Treasurer - [O] | 25,000 | 1,667 | |
| Robert G L Shorr Director - [D] | 45,731 | 3,049 | |
| Chen Schor Director - [D] | 121,558 | 8,104 | |
| David Setboun EVP and COO - [O] | 55,000 | 3,667 | |
| Preetam Shah EVP, CFO and Treasurer - [O] | 11,600 | 773 | |
| Liat Sossover | 100,000 | ||
| Malcolm S Taub Director - [D] | 77,332 | 5,155 | |
| Kirk Taylor Chief Medical Officer - [O] | 35,000 | 2,333 | |
| Anthony Waclawski See Remarks - [O] | 35,000 | 2,333 | |
| Uri Yablonka EVP & Chief Business Officer, Director - [D] [O] | 68,464 | 68,464 |
Report errors via our new Insider Auditing Tool
Rekod Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam BCLI / Brainstorm Cell Therapeutics Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.
Rekod Jejak Jualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam BCLI / Brainstorm Cell Therapeutics Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.
Sejarah Transaksi
Klik ikon pautan untuk melihat sejarah transaksi penuh. Transaksi yang dilaporkan sebagai sebahagian daripada pelan dagangan automatik 10b5-1 akan mempunyai X dalam lajur bertanda 10b-5.
| Fail Tarikh |
Dagangan Tarikh |
Borang | Orang dalam | Simbol Saham | Nama Sekuriti | Kod | Langsung | Harga Pelaksanaan |
Harga Unit |
Unit Berubah |
Nilai Berubah (1K) |
Baki Opsyen |
Baki Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-07 | 2025-01-01 | 4 | Dagher Ibrahim B. | BCLI | Common Stock | D | 50,000 | 66,849 | ||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. | BCLI | Common Stock | D | 315,742 | ||||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. By the Reporting Person's Roth IRA | BCLI | Common Stock | I | 160,000 | ||||||||
| 2025-01-07 | 3/A | Dagher Ibrahim B. See Note | BCLI | Common Stock | I | 30,000 | ||||||||
| 2025-01-03 | 2025-01-01 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 120,000 | 200,960 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | FRENKEL JACOB A | BCLI | Common Stock | D | 40,000 | 43,777 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 24,000 | 25,730 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Yablonka Uri | BCLI | Common Stock | D | 20,000 | 68,464 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Yablonka Uri | BCLI | Common Stock | D | 40,000 | 48,464 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Naor Nir | BCLI | Common Stock | D | 30,666 | 31,465 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Patlis Alla | BCLI | Common Stock | D | 40,000 | 44,349 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | HARTOUNIAN HARTOUN | BCLI | Common Stock | D | 50,000 | 52,000 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 20,000 | 48,229 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | Bairu Menghisteab | BCLI | Common Stock | D | 24,000 | 24,000 | ||||||
| 2025-01-03 | 2025-01-01 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 30,666 | 41,054 | ||||||
| 2024-10-02 | 2024-10-01 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 3.4272 | 1,836 | 6 | 80,960 | ||||
| 2024-10-02 | 2024-09-30 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.2280 | 22,000 | 5 | 1,186,865 | ||||
| 2024-07-31 | 2024-05-22 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.6400 | 25,000 | 16 | 1,149,865 | ||||
| 2024-07-31 | 2024-05-21 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.5790 | 25,000 | 14 | 1,124,865 | ||||
| 2024-07-31 | 2024-05-28 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.5183 | 15,000 | 8 | 1,164,865 | ||||
| 2024-07-31 | 2024-05-13 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.4900 | 10,000 | 5 | 1,099,865 | ||||
| 2024-07-31 | 2024-05-11 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.4665 | 10,000 | 5 | 1,089,865 | ||||
| 2024-07-31 | 2024-05-10 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.4650 | 20,000 | 9 | 1,079,865 | ||||
| 2024-07-31 | 2024-05-06 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.3753 | 135,000 | 51 | 993,565 | ||||
| 2024-07-31 | 2024-05-07 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.3743 | 66,300 | 25 | 1,059,865 | ||||
| 2024-07-31 | 2024-04-19 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.5199 | 15,000 | 8 | 858,565 | ||||
| 2024-07-31 | 2024-04-18 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.5255 | 115,072 | 60 | 843,565 | ||||
| 2024-07-31 | 2024-04-17 | 4/A | Lebovits Chaim | BCLI | Common Stock | D | 0.5457 | 130,000 | 71 | 728,493 | ||||
| 2024-07-24 | 2024-07-19 | 4 | Dagher Ibrahim B. | BCLI | Common Stock | D | 0.3503 | -63,000 | -22 | 0 | ||||
| 2024-06-25 | 2024-06-24 | 4 | HARTOUNIAN HARTOUN | BCLI | Common Stock | D | 30,000 | 30,000 | ||||||
| 2024-06-03 | 2024-05-28 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.5183 | 15,000 | 8 | 1,164,865 | ||||
| 2024-05-23 | 2024-05-22 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.6400 | 25,000 | 16 | 1,149,865 | ||||
| 2024-05-23 | 2024-05-21 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.5790 | 25,000 | 14 | 1,124,865 | ||||
| 2024-05-14 | 2024-05-13 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.4900 | 10,000 | 5 | 1,099,865 | ||||
| 2024-05-14 | 2024-05-11 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.4665 | 10,000 | 5 | 1,089,865 | ||||
| 2024-05-14 | 2024-05-10 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.4650 | 20,000 | 9 | 1,079,865 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.3743 | 66,300 | 25 | 1,059,865 | ||||
| 2024-05-07 | 2024-05-06 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.3753 | 135,000 | 51 | 993,565 | ||||
| 2024-04-25 | 2024-04-19 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.5199 | 15,000 | 8 | 858,565 | ||||
| 2024-04-22 | 3 | Dagher Ibrahim B. | BCLI | Common Stock | D | 63,000 | ||||||||
| 2024-04-22 | 3 | Dagher Ibrahim B. See Note | BCLI | Common Stock | I | 30,000 | ||||||||
| 2024-04-22 | 3 | Dagher Ibrahim B. By the Reporting Person's Roth IRA | BCLI | Common Stock | I | 160,000 | ||||||||
| 2024-04-19 | 2024-04-18 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.5255 | 115,072 | 60 | 843,565 | ||||
| 2024-04-19 | 2024-04-17 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 0.5457 | 130,000 | 71 | 728,493 | ||||
| 2024-03-13 | 2024-03-11 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 241,935 | 423,435 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Yablonka Uri | BCLI | Common Stock | D | 109,426 | 126,969 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Patlis Alla | BCLI | Common Stock | D | 65,246 | 65,246 | ||||||
| 2024-03-13 | 2024-03-11 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 305,198 | 598,493 | ||||||
| 2023-09-05 | 2023-09-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 1.7741 | 11,500 | 20 | 181,500 | ||||
| 2023-08-07 | 2023-08-02 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 35,000 | 170,000 | ||||||
| 2023-08-04 | 2023-08-02 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31,185 | 293,295 | ||||||
| 2023-06-21 | 2023-06-19 | 4 | Naor Nir | BCLI | Common Stock | D | 11,999 | 11,999 | ||||||
| 2023-05-01 | 2023-05-01 | 4 | Taylor Kirk | BCLI | Common Stock | D | 35,000 | 35,000 | ||||||
| 2023-04-24 | 2023-04-20 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 75,000 | 262,110 | ||||||
| 2023-04-24 | 2023-04-20 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 75,000 | 135,000 | ||||||
| 2023-01-04 | 2022-12-07 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 35,000 | 60,000 | ||||||
| 2023-01-04 | 2022-09-18 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31,185 | 187,110 | ||||||
| 2022-04-08 | 2022-04-06 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0.75 | 50,000 | 50,000 | |||||
| 2022-03-14 | 2022-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35,885 | 223,310 | ||||||
| 2022-02-03 | 2022-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3,882 | 25,960 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2,000 | 22,078 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12,000 | 77,332 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2,000 | 6,000 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0.75 | 13,333 | 13,333 | |||||
| 2021-12-17 | 2021-12-15 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 25,333 | 25,333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35,885 | 187,425 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12,000 | 65,332 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31,185 | 155,925 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2,000 | 20,078 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2,216 | 18,078 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 25,333 | 25,333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0.75 | 13,333 | 13,333 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Abbhi Sankesh | BCLI | Common Stock | D | 6,666 | 11,323 | ||||||
| 2021-12-10 | 2021-12-10 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0.75 | 50,000 | 50,000 | |||||
| 2021-12-10 | 2021-12-10 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2,000 | 4,000 | ||||||
| 2020-12-31 | 2020-12-30 | 4 | Shah Preetam | BCLI | Common Stock | D | 4.6400 | -25,000 | -116 | 11,600 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Lindborg Stacy | BCLI | Call Option (right to buy) | D | 10.00 | 11,000.0000 | 200 | 2,200 | 200 | |||
| 2020-09-10 | 2020-09-08 | 4 | Waclawski Anthony | BCLI | Stock Option (Right to Buy) | D | 12.58 | 80,000 | 80,000 | |||||
| 2020-09-10 | 2020-09-08 | 4 | Waclawski Anthony | BCLI | Common Stock | D | 35,000 | 35,000 | ||||||
| 2020-07-31 | 2020-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31,185 | 124,740 | ||||||
| 2020-07-16 | 2020-07-15 | 4 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 12.9900 | 46,779 | 608 | 2,164,530 | ||||
| 2020-07-16 | 2020-07-16 | 4 | Setboun David | BCLI | Common Stock | D | 12.9480 | 5,000 | 65 | 55,000 | ||||
| 2020-07-16 | 2020-07-16 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13.4668 | -7,823 | -105 | 67,053 | ||||
| 2020-07-16 | 2020-07-15 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13.1153 | -18,430 | -242 | 74,876 | ||||
| 2020-07-16 | 2020-07-13 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13.5238 | -40,000 | -541 | 93,306 | ||||
| 2020-07-16 | 2020-07-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13.3500 | -2,000 | -27 | 133,306 | ||||
| 2020-07-16 | 2020-07-09 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 13.1253 | -3,500 | -46 | 135,306 | ||||
| 2020-06-26 | 2020-06-23 | 4 | Yablonka Uri | BCLI | Common Stock | D | 10,000 | 17,543 | ||||||
| 2020-06-01 | 2020-06-01 | 4 | Lindborg Stacy | BCLI | Stock Option (right to buy) | D | 7.67 | 100,000 | 100,000 | |||||
| 2020-06-01 | 2020-06-01 | 4 | Lindborg Stacy | BCLI | Common Stock | D | 25,000 | 25,000 | ||||||
| 2020-04-07 | 2020-04-06 | 4 | FRENKEL JACOB A | BCLI | Stock Option (right to buy) | D | 0.75 | 50,000 | 50,000 | |||||
| 2020-04-07 | 2020-04-07 | 4 | Setboun David | BCLI | Common Stock | D | 50,000 | 50,000 | ||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4,235,502 | ||||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4,235,502 | ||||||||
| 2020-04-07 | 3 | Abbhi Sankesh Abbhi Investments, LLC | BCLI | Common Stock | I | 4,235,502 | ||||||||
| 2020-04-07 | 2020-04-06 | 4 | Abbhi Sankesh | BCLI | Common Stock | D | 4,657 | 4,657 | ||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113,334 | ||||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113,334 | ||||||||
| 2020-04-07 | 3 | FRENKEL JACOB A | BCLI | Common Stock | D | 113,334 | ||||||||
| 2020-03-13 | 2020-03-09 | 4 | Kern Ralph Dr. | BCLI | Stock Option (right to buy) | D | 7.33 | 80,000 | 80,000 | |||||
| 2020-03-06 | 2020-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35,885 | 151,540 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 25,333 | 25,333 | |||||
| 2020-02-14 | 2019-12-12 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12,000 | 53,332 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0.75 | 13,333 | 13,333 | |||||
| 2020-02-14 | 2019-12-12 | 4 | Almenoff June Sherie | BCLI | Common Stock | D | 2,000 | 2,000 | ||||||
| 2020-02-14 | 2020-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3,071 | 15,862 | ||||||
| 2020-02-14 | 2019-12-12 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2,000 | 12,791 | ||||||
| 2019-12-27 | 2019-12-24 | 4 | Araya Arturo | BCLI | Common Stock | D | 3.9000 | 3,000 | 12 | 8,608 | ||||
| 2019-12-27 | 2019-12-24 | 4 | Shah Preetam | BCLI | Common Stock | D | 3.9594 | 11,600 | 46 | 36,600 | ||||
| 2019-12-27 | 2019-12-24 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 3.8800 | 3,000 | 12 | 115,655 | ||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Stock Option (right to buy) | D | 3.96 | 100,000 | 100,000 | |||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Stock Option (right to buy) | D | 6.00 | 100,000 | 100,000 | |||||
| 2019-09-09 | 2019-09-06 | 4 | Shah Preetam | BCLI | Common Stock | D | 25,000 | 25,000 | ||||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 2.25 | -6,666 | 0 | |||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 2.25 | -6,666 | 0 | |||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 3.6672 | -13,332 | -49 | 155,833 | ||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 2.2500 | 6,666 | 15 | 169,165 | ||||
| 2019-08-30 | 2019-08-28 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 2.2500 | 6,666 | 15 | 169,165 | ||||
| 2019-07-26 | 2019-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31,185 | 2,166,155 | ||||||
| 2019-03-08 | 2019-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35,885 | 112,655 | ||||||
| 2019-02-22 | 2019-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3,501 | 10,791 | ||||||
| 2019-01-08 | 2019-01-04 | 4 | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3.3900 | 1,475 | 5 | 7,175 | ||||
| 2018-12-21 | 2018-10-24 | 4 | Schor Chen By The C. Schor Irrevocable Trust | BCLI | Common Stock | I | 121,558 | 121,558 | ||||||
| 2018-12-21 | 2018-10-24 | 4 | Schor Chen | BCLI | Common Stock | D | -121,558 | 4,000 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12,000 | 41,332 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0.75 | 13,333 | 13,333 | |||||
| 2018-11-30 | 2018-11-30 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 25,333 | 25,333 | |||||
| 2018-11-30 | 2018-11-30 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 1,667 | 7,290 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 2,000 | 5,623 | ||||||
| 2018-11-30 | 2018-11-30 | 4 | Schor Chen | BCLI | Common Stock | D | 2,000 | 125,558 | ||||||
| 2018-09-04 | 2018-08-28 | 4 | Araya Arturo | BCLI | Stock Option (right to buy) | D | 3.98 | 200,000 | 200,000 | |||||
| 2018-09-04 | 2018-08-28 | 4 | Araya Arturo | BCLI | Common Stock | D | -2,805 | 5,608 | ||||||
| 2018-07-27 | 2018-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31,185 | 2,134,970 | ||||||
| 2018-03-26 | 2018-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35,885 | 76,770 | ||||||
| 2018-03-26 | 2018-03-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 1,249 | 8,413 | ||||||
| 2018-03-20 | 2018-03-15 | 4/A | Kern Ralph Dr. | BCLI | Common Stock | D | 3.5994 | 5,000 | 18 | 40,885 | ||||
| 2018-03-20 | 2018-03-15 | 4/A | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3.5000 | 5,700 | 20 | 5,700 | ||||
| 2018-03-19 | 2018-03-15 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 3.5994 | 5,000 | 18 | 40,885 | ||||
| 2018-03-16 | 2018-03-15 | 4 | Almenoff June Sherie By Meadowlark Management LLC | BCLI | Common Stock | I | 3.5000 | 5,700 | 20 | 5,700 | ||||
| 2018-02-28 | 2018-02-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 4,152 | 7,164 | ||||||
| 2018-02-05 | 2018-02-01 | 4 | Polverino Anthony J. | BCLI | Common Stock | D | 3,623 | 3,623 | ||||||
| 2017-11-20 | 2017-11-20 | 4 | Rubin Eyal | BCLI | Stock Option (right to buy) | D | 4.30 | 93,686 | 93,686 | |||||
| 2017-11-20 | 2017-11-20 | 4 | Rubin Eyal | BCLI | Common Stock | D | 25,000 | 25,000 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Schor Chen | BCLI | Common Stock | D | 2,000 | 123,558 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 12,000 | 29,332 | ||||||
| 2017-11-13 | 2017-11-10 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0.75 | 13,333 | 13,333 | |||||
| 2017-11-13 | 2017-11-10 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 25,333 | 25,333 | |||||
| 2017-11-13 | 2017-11-10 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8,666 | 45,731 | ||||||
| 2017-08-31 | 2017-08-31 | 4 | ARBEL IRIT | BCLI | Common Stock | D | 4.2600 | 2,500 | 11 | 155,833 | ||||
| 2017-08-23 | 2017-08-23 | 4 | Yablonka Uri | BCLI | Common Stock | D | 3.9800 | 2,000 | 8 | 7,543 | ||||
| 2017-07-26 | 2017-07-26 | 4 | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 4.81 | 41,580 | 41,580 | |||||
| 2017-07-26 | 2017-07-26 | 4 | Lebovits Chaim | BCLI | Common Stock | D | 31,185 | 2,103,785 | ||||||
| 2017-07-17 | 2017-07-13 | 4 | Yablonka Uri | BCLI | Common Stock | D | 5,543 | 5,543 | ||||||
| 2017-07-17 | 2017-07-13 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 12,000 | 12,000 | |||||
| 2017-03-06 | 2017-03-06 | 4 | Kern Ralph Dr. | BCLI | Stock Option (right to buy) | D | 4.18 | 47,847 | 47,847 | |||||
| 2017-03-06 | 2017-03-06 | 4 | Kern Ralph Dr. | BCLI | Common Stock | D | 35,885 | 35,885 | ||||||
| 2017-03-03 | 2017-02-26 | 4 | Araya Arturo | BCLI | Common Stock | D | 3,012 | 3,012 | ||||||
| 2017-02-28 | 2017-02-26 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 6,667 | 6,667 | |||||
| 2016-06-23 | 2016-06-22 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8,666 | 37,065 | ||||||
| 2016-06-23 | 2016-06-22 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 25,333 | 25,333 | |||||
| 2016-06-23 | 2016-06-22 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 8,666 | 17,332 | ||||||
| 2016-06-23 | 2016-06-22 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0.75 | 15,333 | 15,333 | |||||
| 2016-06-23 | 2016-06-22 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0.75 | 16,666 | 16,666 | |||||
| 2016-06-23 | 2016-06-22 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0.75 | 13,333 | 13,333 | |||||
| 2015-12-17 | 2015-12-16 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2.7100 | -10,800 | -29 | 28,399 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0.75 | -5,000 | 11,666 | |||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Common Stock | D | 2.5700 | -5,000 | -13 | 0 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Friedman Mordechai | BCLI | Common Stock | D | 0.7500 | 5,000 | 4 | 5,000 | ||||
| 2015-12-16 | 2015-12-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2.5900 | -11,263 | -29 | 8,666 | ||||
| 2015-12-16 | 2015-12-14 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2.6100 | -30,479 | -80 | 19,929 | ||||
| 2015-12-14 | 2015-12-11 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2.6600 | -980 | -3 | 50,408 | ||||
| 2015-12-14 | 2015-12-10 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 2.7400 | -12,500 | -34 | 51,388 | ||||
| 2015-12-14 | 2015-12-11 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2.5600 | -5,300 | -14 | 39,199 | ||||
| 2015-12-14 | 2015-12-10 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 2.7100 | -5,500 | -15 | 44,499 | ||||
| 2015-12-03 | 2015-12-01 | 4 | Bibring Yoram | BCLI | Stock Option (right to buy) | D | 3.17 | 82,500 | 82,500 | |||||
| 2015-10-13 | 2015-09-28 | 4/A | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 2.45 | 369,619 | 369,619 | |||||
| 2015-10-02 | 2015-10-01 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 2.5800 | 2,000 | 5 | 138,806 | ||||
| 2015-10-01 | 2015-09-28 | 4 | Lebovits Chaim | BCLI | Stock Option (right to buy) | D | 2.45 | 369,619 | 369,619 | |||||
| 2015-10-01 | 2015-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 2.3400 | 9,200 | 22 | 136,806 | ||||
| 2015-08-31 | 2015-08-27 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 8,666 | 49,999 | ||||||
| 2015-08-31 | 2015-08-27 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0.75 | 13,333 | 13,333 | |||||
| 2015-08-31 | 2015-08-27 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 8,666 | 50,554 | ||||||
| 2015-08-31 | 2015-08-27 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0.75 | 15,333 | 15,333 | |||||
| 2015-08-31 | 2015-08-27 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0.75 | 16,666 | 16,666 | |||||
| 2015-08-31 | 2015-08-27 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 25,333 | 25,333 | |||||
| 2015-08-21 | 2015-08-20 | 4 | Bibring Yoram | BCLI | Common Stock | D | 3.0400 | 8,500 | 26 | 50,000 | ||||
| 2015-08-19 | 2015-08-17 | 4 | Bibring Yoram | BCLI | Common Stock | D | 2.9200 | 41,500 | 121 | 41,500 | ||||
| 2015-08-03 | 2015-07-30 | 4 | Bibring Yoram | BCLI | Stock Option (right to buy) | D | 3.17 | 165,000 | 165,000 | |||||
| 2015-06-03 | 2015-06-01 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.75 | 6,667 | 6,667 | |||||
| 2015-05-05 | 2015-05-03 | 4 | Schor Chen | BCLI | Common Stock | D | 60,000 | 121,558 | ||||||
| 2014-10-15 | 2014-10-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3.5990 | 300 | 1 | 2,500 | ||||
| 2014-10-15 | 2014-10-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3.5900 | 200 | 1 | 2,200 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3.9999 | 300 | 1 | 127,606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3.9499 | 700 | 3 | 127,306 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3.9500 | 300 | 1 | 126,606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.0100 | 400 | 2 | 126,306 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3.9799 | 400 | 2 | 125,906 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3.9799 | 1,300 | 5 | 125,506 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.0099 | 600 | 2 | 124,206 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.0399 | 600 | 2 | 123,606 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.0500 | 300 | 1 | 123,006 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.0799 | 200 | 1 | 122,706 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.0899 | 2,500 | 10 | 122,506 | ||||
| 2014-10-15 | 2014-10-10 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.2900 | 1,000 | 4 | 120,006 | ||||
| 2014-10-01 | 2014-10-01 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.0799 | 3,600 | 15 | 119,006 | ||||
| 2014-10-01 | 2014-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.3200 | 1,000 | 4 | 115,406 | ||||
| 2014-10-01 | 2014-09-30 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.2150 | 500 | 2 | 114,406 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.1200 | 1,000 | 4 | 113,906 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.1700 | 500 | 2 | 112,906 | ||||
| 2014-10-01 | 2014-09-29 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.1800 | 100 | 0 | 112,406 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.3000 | 1,800 | 8 | 112,306 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.2900 | 2,000 | 9 | 110,506 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.2800 | 400 | 2 | 108,506 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.2700 | 1,000 | 4 | 108,106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.2300 | 1,200 | 5 | 107,106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.2000 | 500 | 2 | 105,906 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.1800 | 300 | 1 | 105,406 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.1400 | 500 | 2 | 105,106 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.1000 | 300 | 1 | 104,606 | ||||
| 2014-09-24 | 2014-09-22 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 4.0500 | 500 | 2 | 104,306 | ||||
| 2014-09-24 | 2014-09-19 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3.9400 | 1,000 | 4 | 103,806 | ||||
| 2014-09-24 | 2014-09-19 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 3.9000 | 1,500 | 6 | 102,806 | ||||
| 2014-09-19 | 2014-09-18 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 3.8400 | 800 | 3 | 2,000 | ||||
| 2014-09-16 | 2014-09-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0.2835 | 3,000 | 1 | 18,000 | ||||
| 2014-09-16 | 2014-09-15 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0.2875 | 5,000 | 1 | 15,000 | ||||
| 2014-09-16 | 2014-09-12 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0.2850 | 7,500 | 2 | 10,000 | ||||
| 2014-09-16 | 2014-09-12 | 4 | Fiorino Anthony S. | BCLI | Common Stock | D | 0.2800 | 2,500 | 1 | 2,500 | ||||
| 2014-08-19 | 2014-08-15 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130,000 | 620,000 | ||||||
| 2014-08-19 | 2014-08-15 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.05 | 380,000 | 380,000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130,000 | 628,333 | ||||||
| 2014-08-19 | 2014-08-15 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0.05 | 230,000 | 230,000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0.05 | 250,000 | 250,000 | |||||
| 2014-08-19 | 2014-08-15 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0.05 | 200,000 | 200,000 | |||||
| 2014-06-20 | 2014-06-16 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0.2900 | 130,000 | 38 | 1,519,600 | ||||
| 2014-06-16 | 2014-06-13 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0.3500 | 150,000 | 52 | 1,389,600 | ||||
| 2014-06-10 | 2014-06-09 | 4 | Fiorino Anthony S. | BCLI | Stock Option (right to buy) | D | 0.30 | 5,700,000 | 5,700,000 | |||||
| 2014-06-09 | 2014-06-06 | 4 | Yablonka Uri | BCLI | Stock Option (right to buy) | D | 0.18 | 500,000 | 500,000 | |||||
| 2014-05-02 | 2014-04-28 | 4 | ACC International Holdings Ltd. | BCLI | Common Stock | D | 0.3000 | 939,600 | 282 | 1,239,600 | ||||
| 2014-04-14 | 2014-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 133,334 | 133,334 | ||||||
| 2014-04-14 | 2014-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166,666 | 166,666 | ||||||
| 2014-01-03 | 2013-12-31 | 4 | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0.18 | 100,000 | 100,000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130,000 | 490,000 | ||||||
| 2013-04-23 | 2013-04-19 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.15 | 180,000 | 180,000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130,000 | 498,333 | ||||||
| 2013-04-23 | 2013-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166,666 | 166,666 | ||||||
| 2013-04-23 | 2013-04-19 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0.15 | 130,000 | 130,000 | |||||
| 2013-04-23 | 2013-04-19 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0.15 | 150,000 | 150,000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | ARBEL IRIT | BCLI | Stock Option (right to buy) | D | 0.15 | 180,000 | 180,000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | Pinkas Alon | BCLI | Stock Option (right to buy) | D | 0.15 | 130,000 | 130,000 | |||||
| 2012-09-06 | 2012-08-01 | 4 | Friedman Mordechai | BCLI | Stock Option (right to buy) | D | 0.15 | 150,000 | 150,000 | |||||
| 2012-08-27 | 2012-08-01 | 4/A | Harel Adrian | BCLI | Stock Option (right to buy) | D | 0.26 | 70,000 | 70,000 | |||||
| 2012-08-27 | 2012-08-01 | 4/A | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0.26 | 60,000 | 60,000 | |||||
| 2012-08-03 | 2012-08-01 | 4 | SHORR ROBERT G L | BCLI | Common Stock | D | 130,000 | 360,000 | ||||||
| 2012-08-03 | 2012-08-01 | 4 | TAUB MALCOLM S | BCLI | Common Stock | D | 130,000 | 368,333 | ||||||
| 2012-08-03 | 2012-08-01 | 4 | Sossover Liat | BCLI | Stock Option (right to buy) | D | 0.26 | 60,000 | 60,000 | |||||
| 2012-08-03 | 2012-08-01 | 4 | Harel Adrian | BCLI | Stock Option (right to buy) | D | 0.26 | 70,000 | 70,000 | |||||
| 2012-04-17 | 2012-04-13 | 4 | Israeli Avi | BCLI | Stock Option (right to buy) | D | 166,666 | 166,666 | ||||||
| 2009-04-03 | 3 | TAUB MALCOLM S | BCLI | Common Stock | D | 1,250,000 | ||||||||
| 2007-08-08 | 2007-08-02 | 4 | ACCBT Corp. | BCLI | Right to Acquire Warrant to Purchase Common Stock | D | 636,385.00 | 3,181,925 | 3,181,925 |
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)
